Botulinum TOX TYP a 1S
Ended Awarded
- Contract number
- SPE2DR26FBTBR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,858
Award facts
- Contract value 100% obligated
- $10,858.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $10,858.07 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botulinum Toxin Type A. DMS Pharmaceutical Group, which has been registered in the System for Award Management since 2001, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order carries a firm fixed-price structure with an ultimate completion date of November 21, 2025, and will be performed at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying PPV-G GEN V contract, awarded November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion acquisition strategy. The PPV-G GEN V framework authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide, with DMS Pharmaceutical Group's demonstrated performance on numerous prior delivery orders confirming its capability to meet the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTBR?
SPE2DR26FBTBR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26FBTBR worth?
The government has obligated $10,858 on SPE2DR26FBTBR.
Is contract SPE2DR26FBTBR an order under another contract?
Yes. SPE2DR26FBTBR is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTBR competed?
The extent of competition for SPE2DR26FBTBR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award